SCHEMBL4836267

SCHEMBL4836267

CCCCC1CCCC1O

nearest known ligand 0.68

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.68
CA2 P00918 1/20 0.68
CA4 P22748 1/20 0.68
CYP1A2 P05177 1/20 0.43
LSS P48449 2/20 0.37
GLB1 P16278 2/20 0.36
DPP4 P27487 1/20 0.35
PTGS1 P23219 7/20 0.33
PTGS2 P35354 6/20 0.33
MT-CO1 P00395 1/20 0.33
MT-CO2 P00403 1/20 0.33
ALOX5 P09917 1/20 0.33
LMNA P02545 1/20 0.32
MAPK1 P28482 1/20 0.32
HTT P42858 1/20 0.32
GBA1 P04062 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14424441 1.00 CA1 (0.68) CA1CA2CA4CYP1A2LSS
SCHEMBL4640300 0.95 CA1 (0.75) CA1CA2CA4CYP1A2LSS
SCHEMBL4843233 0.93 CA1 (0.72) CA1CA2CA4CYP1A2LSS
SCHEMBL694436 0.93 CA1 (0.65) CA1CA2CA4CYP1A2LSS
SCHEMBL30879546 0.93 CA1 (0.65) CA1CA2CA4CYP1A2LSS
SCHEMBL4844470 0.93 CA1 (0.72) CA1CA2CA4CYP1A2LSS
SCHEMBL669599 0.93 CA1 (0.65) CA1CA2CA4CYP1A2LSS
SCHEMBL1391670 0.93 CA1 (0.65) CA1CA2CA4CYP1A2LSS
SCHEMBL23542639 0.91 CA1 (0.63) CA1CA2CA4LSSGLB1
SCHEMBL16766627 0.91 CA1 (0.63) CA1CA2CA4LSSGLB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119923435-A Polyalkylene carbonate resin composition and method for preparing the same 株式会社LG化学 2025-05-02 CN claimed
CN-119744281-A Polyalkylene carbonate resin composition and method for preparing the same 株式会社LG化学 2025-04-01 CN claimed
CN-117916020-A Double metal cyanide catalysts, methods of preparing the same, and methods of preparing polyalkylene carbonates using the same 株式会社LG化学 2024-04-19 CN claimed
CN-116848175-A Method for preparing polyalkylene carbonate resin 株式会社LG化学 2023-10-03 CN claimed
CN-119923435-A Polyalkylene carbonate resin composition and method for preparing the same 株式会社LG化学 2025-05-02 CN disclosed
CN-119744281-A Polyalkylene carbonate resin composition and method for preparing the same 株式会社LG化学 2025-04-01 CN disclosed
CN-117916020-A Double metal cyanide catalysts, methods of preparing the same, and methods of preparing polyalkylene carbonates using the same 株式会社LG化学 2024-04-19 CN disclosed
CN-116848175-A Method for preparing polyalkylene carbonate resin 株式会社LG化学 2023-10-03 CN disclosed
EP-1710223-B1 PROCESS FOR PRODUCING ALDEHYDE COMPOUND OR KETONE COMPOUND WITH USE OF MICROREACTOR UBE INDUSTRIES (JP) 2012-10-31 EP disclosed
US-7332632-B2 Method for producing aldehyde compound or ketone compound by using microreactor Ubē Industries, Ltd. (JP) 2008-02-19 US disclosed
US-20070149823-A1 Method for producing aldehyde compound or ketone compound by using microreactor UBE INDUSTRIES, LTD., A CORPORATION OF JAPAN (JP) 2007-06-28 US disclosed
EP-1710223-A1 PROCESS FOR PRODUCING ALDEHYDE COMPOUND OR KETONE COMPOUND WITH USE OF MICROREACTOR Ube Industries, Ltd. (JP) 2006-10-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070149823-A1 Method for producing aldehyde compound or ketone compound by using microreactor ADH1C, ADH1A, ALDH1A1 CA1 1026/4885CA2 2767/4885CA4 1056/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.